Activated lymphocytes as a metabolic model for carcinogenesis

[1]  P. Vaupel,et al.  Availability, not respiratory capacity governs oxygen consumption of solid tumors. , 2012, The international journal of biochemistry & cell biology.

[2]  Wei Liu,et al.  Reprogramming of proline and glutamine metabolism contributes to the proliferative and metabolic responses regulated by oncogenic transcription factor c-MYC , 2012, Proceedings of the National Academy of Sciences.

[3]  Navdeep S. Chandel,et al.  AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stress , 2012, Nature.

[4]  P. Pandolfi,et al.  The functions and regulation of the PTEN tumour suppressor , 2012, Nature Reviews Molecular Cell Biology.

[5]  J. Rathmell,et al.  Metabolic pathways in T cell fate and function. , 2012, Trends in immunology.

[6]  D. Hardie,et al.  AMPK: a nutrient and energy sensor that maintains energy homeostasis , 2012, Nature Reviews Molecular Cell Biology.

[7]  C. Feschotte,et al.  Endogenous viruses: insights into viral evolution and impact on host biology , 2012, Nature Reviews Genetics.

[8]  T. Fan,et al.  The metabolic profile of tumors depends on both the responsible genetic lesion and tissue type. , 2012, Cell metabolism.

[9]  C. Tournier,et al.  Exploring the function of the JNK (c-Jun N-terminal kinase) signalling pathway in physiological and pathological processes to design novel therapeutic strategies. , 2012, Biochemical Society transactions.

[10]  A. Nebreda,et al.  Roles of p38 MAPKs in invasion and metastasis. , 2012, Biochemical Society transactions.

[11]  B. Kholodenko,et al.  Cross-talk between mitogenic Ras/MAPK and survival PI3K/Akt pathways: a fine balance. , 2012, Biochemical Society transactions.

[12]  G. V. D. van der Windt,et al.  Mitochondrial respiratory capacity is a critical regulator of CD8+ T cell memory development. , 2012, Immunity.

[13]  Christian M. Metallo,et al.  Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia , 2011, Nature.

[14]  D. Green,et al.  The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation. , 2011, Immunity.

[15]  M. Dwyer,et al.  Estrogen-related receptor-α is a metabolic regulator of effector T-cell activation and differentiation , 2011, Proceedings of the National Academy of Sciences.

[16]  Takla Griss,et al.  The Liver Kinase B1 Is a Central Regulator of T Cell Development, Activation, and Metabolism , 2011, The Journal of Immunology.

[17]  Andrei L Osterman,et al.  Comparative Metabolic Flux Profiling of Melanoma Cell Lines , 2011, The Journal of Biological Chemistry.

[18]  M. V. Vander Heiden,et al.  Aerobic glycolysis: meeting the metabolic requirements of cell proliferation. , 2011, Annual review of cell and developmental biology.

[19]  M. Prados,et al.  An LXR agonist promotes glioblastoma cell death through inhibition of an EGFR/AKT/SREBP-1/LDLR-dependent pathway. , 2011, Cancer discovery.

[20]  G. Semenza,et al.  Control of TH17/Treg Balance by Hypoxia-Inducible Factor 1 , 2011, Cell.

[21]  Olaf Wolkenhauer,et al.  Systems biology of JAK-STAT signalling in human malignancies. , 2011, Progress in biophysics and molecular biology.

[22]  J. Chi,et al.  Glutamine Synthetase Is a Genetic Determinant of Cell Type–Specific Glutamine Independence in Breast Epithelia , 2011, PLoS genetics.

[23]  A. Ohta,et al.  In vivo T Cell Activation in Lymphoid Tissues is Inhibited in the Oxygen-Poor Microenvironment , 2011, Front. Immun..

[24]  D. Green,et al.  HIF1α–dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells , 2011, The Journal of experimental medicine.

[25]  S. Mazurek.  Pyruvate kinase type M2: a key regulator of the metabolic budget system in tumor cells. , 2011, The international journal of biochemistry & cell biology.

[26]  Zhengyu Zha,et al.  Acetylation targets the M2 isoform of pyruvate kinase for degradation through chaperone-mediated autophagy and promotes tumor growth. , 2011, Molecular cell.

[27]  R. Deberardinis,et al.  Pyruvate carboxylase is required for glutamine-independent growth of tumor cells , 2011, Proceedings of the National Academy of Sciences.

[28]  J. Rathmell,et al.  Cutting Edge: Distinct Glycolytic and Lipid Oxidative Metabolic Programs Are Essential for Effector and Regulatory CD4+ T Cell Subsets , 2011, The Journal of Immunology.

[29]  Massimo Loda,et al.  Metabolic alterations and targeted therapies in prostate cancer , 2011, The Journal of pathology.

[30]  M. Nawijn,et al.  For better or for worse: the role of Pim oncogenes in tumorigenesis , 2011, Nature Reviews Cancer.

[31]  A. Kraft,et al.  The Pim protein kinases regulate energy metabolism and cell growth , 2010, Proceedings of the National Academy of Sciences.

[32]  O. Ilkayeva,et al.  Akt Requires Glucose Metabolism to Suppress Puma Expression and Prevent Apoptosis of Leukemic T Cells* , 2010, The Journal of Biological Chemistry.

[33]  Kamlesh Asotra,et al.  Calcium wave signaling in cancer cells. , 2010, Life sciences.

[34]  K. Frauwirth,et al.  Induction of Glucose Metabolism in Stimulated T Lymphocytes Is Regulated by Mitogen-Activated Protein Kinase Signaling , 2010, PloS one.

[35]  Taeg S. Kim,et al.  The Cell Cycle Time of CD8+ T Cells Responding In Vivo Is Controlled by the Type of Antigenic Stimulus , 2010, PloS one.

[36]  R. Ricci,et al.  MAPK signalling in cellular metabolism: stress or wellness? , 2010, EMBO reports.

[37]  J. Rathmell,et al.  Aerobic glycolysis suppresses p53 activity to provide selective protection from apoptosis upon loss of growth signals or inhibition of BCR-Abl. , 2010, Cancer research.

[38]  S. Moncada,et al.  Anaphase-promoting complex/cyclosome-Cdh1 coordinates glycolysis and glutaminolysis with transition to S phase in human T lymphocytes , 2010, Proceedings of the National Academy of Sciences.

[39]  H. Waldmann,et al.  mTOR signalling and metabolic regulation of T cell differentiation. , 2010, Current opinion in immunology.

[40]  Jason W. Locasale,et al.  Evidence for an Alternative Glycolytic Pathway in Rapidly Proliferating Cells , 2010, Science.

[41]  K. Frauwirth,et al.  Glutamine Uptake and Metabolism Are Coordinately Regulated by ERK/MAPK during T Lymphocyte Activation , 2010, The Journal of Immunology.

[42]  W. Wheaton,et al.  Mitochondrial metabolism and ROS generation are essential for Kras-mediated tumorigenicity , 2010, Proceedings of the National Academy of Sciences.

[43]  B. Thorens,et al.  Glucose transporters in the 21st Century. , 2010, American journal of physiology. Endocrinology and metabolism.

[44]  T. Seyfried,et al.  Cancer as a metabolic disease , 2010, Nutrition & metabolism.

[45]  E. Génot,et al.  Mitochondrial bioenergetic adaptations of breast cancer cells to aglycemia and hypoxia , 2010, Journal of bioenergetics and biomembranes.

[46]  D. Nomura,et al.  Monoacylglycerol Lipase Regulates a Fatty Acid Network that Promotes Cancer Pathogenesis , 2010, Cell.

[47]  W. Zong,et al.  Akt and c-Myc Differentially Activate Cellular Metabolic Programs and Prime Cells to Bioenergetic Inhibition* , 2009, The Journal of Biological Chemistry.

[48]  Jing Chen,et al.  Tyrosine Phosphorylation Inhibits PKM2 to Promote the Warburg Effect and Tumor Growth , 2009, Science Signaling.

[49]  D. Littman,et al.  Plasticity of CD4+ T cell lineage differentiation. , 2009, Immunity.

[50]  Ute Becherer,et al.  Morphological changes of T cells following formation of the immunological synapse modulate intracellular calcium signals. , 2009, Cell calcium.

[51]  Michael P. Murphy,et al.  How mitochondria produce reactive oxygen species , 2008, The Biochemical journal.

[52]  J. Rathmell,et al.  Glucose Metabolism Attenuates p53 and Puma-dependent Cell Death upon Growth Factor Deprivation* , 2008, Journal of Biological Chemistry.

[53]  Anthony Mancuso,et al.  Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction , 2008, Proceedings of the National Academy of Sciences.

[54]  J. Rathmell,et al.  Glucose metabolism in lymphocytes is a regulated process with significant effects on immune cell function and survival , 2008, Journal of leukocyte biology.

[55]  T. Gajewski,et al.  Glucose deprivation inhibits multiple key gene expression events and effector functions in CD8+ T cells , 2008, European journal of immunology.

[56]  Jan-Ulrich Kreft,et al.  Use of Game-Theoretical Methods in Biochemistry and Biophysics , 2008, Journal of biological physics.

[57]  R. Wittig,et al.  Expression of transketolase-like 1 and activation of Akt in grade IV glioblastomas compared with grades II and III astrocytic gliomas. , 2008, American journal of clinical pathology.

[58]  L. Lefrançois,et al.  Endogenous naive CD8+ T cell precursor frequency regulates primary and memory responses to infection. , 2008, Immunity.

[59]  J. Rathmell,et al.  Glucose Uptake Is Limiting in T Cell Activation and Requires CD28-Mediated Akt-Dependent and Independent Pathways1 , 2008, The Journal of Immunology.

[60]  H. Christofk,et al.  Pyruvate kinase M2 is a phosphotyrosine-binding protein , 2008, Nature.

[61]  Trudy E. Bell,et al.  Gravitational astronomy: Hearing the heavens , 2008, Nature.

[62]  J. Rathmell,et al.  IL-7 promotes Glut1 trafficking and glucose uptake via STAT5-mediated activation of Akt to support T-cell survival. , 2008, Blood.

[63]  E. Hayden.  THE 3-BILLION-DOLLAR QUESTION , 2008 .

[64]  G. Anderson,et al.  Generating intrathymic microenvironments to establish T-cell tolerance , 2007, Nature Reviews Immunology.

[65]  Marion Pepper,et al.  Naive CD4(+) T cell frequency varies for different epitopes and predicts repertoire diversity and response magnitude. , 2007, Immunity.

[66]  Nicola Zamboni,et al.  Deficiency in glutamine but not glucose induces MYC-dependent apoptosis in human cells , 2007, The Journal of cell biology.

[67]  Lewis C. Cantley,et al.  AKT/PKB Signaling: Navigating Downstream , 2007, Cell.

[68]  A. Mobasheri,et al.  Hypoxic Regulation of Glucose Transport, Anaerobic Metabolism and Angiogenesis in Cancer: Novel Pathways and Targets for Anticancer Therapeutics , 2007, Chemotherapy.

[69]  M. Ohh,et al.  The role of hypoxia-inducible factors in cancer , 2007, Cellular and Molecular Life Sciences.

[70]  Sébastien Bonnet,et al.  A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth. , 2007, Cancer cell.

[71]  R. Deberardinis,et al.  Phosphatidylinositol 3-Kinase-dependent Modulation of Carnitine Palmitoyltransferase 1A Expression Regulates Lipid Metabolism during Hematopoietic Cell Growth* , 2006, Journal of Biological Chemistry.

[72]  Linda V. Sinclair,et al.  Differential regulation of T-cell growth by IL-2 and IL-15. , 2006, Blood.

[73]  D. Hardie,et al.  Regulation of the energy sensor AMP-activated protein kinase by antigen receptor and Ca2+ in T lymphocytes , 2006, The Journal of experimental medicine.

[74]  P. Leder,et al.  Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance. , 2006, Cancer cell.

[75]  T. Schulz,et al.  Induction of Oxidative Metabolism by Mitochondrial Frataxin Inhibits Cancer Growth , 2006, Journal of Biological Chemistry.

[76]  M. Fleming,et al.  Pim-1 Ligand-bound Structures Reveal the Mechanism of Serine/Threonine Kinase Inhibition by LY294002* , 2005, Journal of Biological Chemistry.

[77]  Jun Li,et al.  Structural Basis of Constitutive Activity and a Unique Nucleotide Binding Mode of Human Pim-1 Kinase* , 2005, Journal of Biological Chemistry.

[78]  P. Hammerman,et al.  The Pim kinases control rapamycin-resistant T cell survival and activation , 2005, The Journal of experimental medicine.

[79]  T. Braciale,et al.  Activation, Differentiation, and Migration of Naive Virus-Specific CD8+ T Cells during Pulmonary Influenza Virus Infection1 , 2004, The Journal of Immunology.

[80]  A. Alavi,et al.  Akt Stimulates Aerobic Glycolysis in Cancer Cells , 2004, Cancer Research.

[81]  M. Guppy,et al.  Cancer metabolism: facts, fantasy, and fiction. , 2004, Biochemical and biophysical research communications.

[82]  W. Garvey,et al.  Facilitative glucose transporter gene expression in human lymphocytes, monocytes, and macrophages: a role for GLUT isoforms 1, 3, and 5 in the immune response and foam cell formation. , 2004, Blood cells, molecules & diseases.

[83]  P. Vaupel,et al.  l-glutamine: a major substrate for tumor cells in vivo? , 2004, Journal of Cancer Research and Clinical Oncology.

[84]  P. Hammerman,et al.  Akt-Directed Glucose Metabolism Can Prevent Bax Conformation Change and Promote Growth Factor-Independent Survival , 2003, Molecular and Cellular Biology.

[85]  G. Semenza.  Targeting HIF-1 for cancer therapy , 2003, Nature Reviews Cancer.

[86]  C. Thompson,et al.  Activated Akt promotes increased resting T cell size, CD28‐independent T cell growth, and development of autoimmunity and lymphoma , 2003, European journal of immunology.

[87]  John Eric Wilson.  Isozymes of mammalian hexokinase: structure, subcellular localization and metabolic function , 2003, Journal of Experimental Biology.

[88]  L. Leng,et al.  High expression of inducible 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (iPFK-2; PFKFB3) in human cancers. , 2002, Cancer research.

[89]  C. Thompson,et al.  The CD28 signaling pathway regulates glucose metabolism. , 2002, Immunity.

[90]  C. Thompson,et al.  Homeostatic control of lymphocyte survival: potential origins and implications , 2002, Nature Immunology.

[91]  William T. Lee,et al.  Continued Antigen Stimulation Is Not Required During CD4+ T Cell Clonal Expansion1 , 2002, The Journal of Immunology.

[92]  M. Sitkovsky,et al.  Differential Effects of Physiologically Relevant Hypoxic Conditions on T Lymphocyte Development and Effector Functions , 2001, The Journal of Immunology.

[93]  P. Newsholme,et al.  Glutamine Metabolism: Nutritional and Clinical Significance Why Is L-Glutamine Metabolism Important to Cells of the Immune System in Health, Postinjury, Surgery or Infection? , 2001 .

[94]  David R. Plas,et al.  Growth Factors Can Influence Cell Growth and Survival through Effects on Glucose Metabolism , 2001, Molecular and Cellular Biology.

[95]  P. Thibault,et al.  Transcription Factor HIF-1 Is a Necessary Mediator of the Pasteur Effect in Mammalian Cells , 2001, Molecular and Cellular Biology.

[96]  S. Bonhoeffer,et al.  Cooperation and Competition in the Evolution of ATP-Producing Pathways , 2001, Science.

[97]  M. V. Vander Heiden,et al.  In the absence of extrinsic signals, nutrient utilization by lymphocytes is insufficient to maintain either cell size or viability. , 2000, Molecular cell.

[98]  D A Rew,et al.  Cell production rates in human tissues and tumours and their significance. Part II: clinical data. , 2000, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[99]  H. G. Khorana.  Chemical Biology: Selected Papers of H Gobind Khorana (with Introductions) , 2000 .

[100]  D A Rew,et al.  Cell production rates in human tissues and tumours and their significance. Part 1: an introduction to the techniques of measurement and their limitations. , 2000, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[101]  G. Burmester,et al.  Bioenergetics of immune functions: fundamental and therapeutic aspects. , 2000, Immunology today.

[102]  A. Miller.  Therapeutic considerations of L-glutamine: a review of the literature. , 1999, Alternative medicine review : a journal of clinical therapeutic.

[103]  R. Curi,et al.  Metabolic fate of glutamine in lymphocytes, macrophages and neutrophils. , 1999, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[104]  A. Saltiel,et al.  Chemical biology , 1999, Current opinion in chemical biology.

[105]  P. Calder,et al.  Cytokine production by human peripheral blood mononuclear cells: differential senstivity to glutamine availability. , 1998, Cytokine.

[106]  D. Wilmore,et al.  Role of glutamine in immunologic responses. , 1998, Nutrition.

[107]  R. D. Williams,et al.  Oxythiamine and dehydroepiandrosterone inhibit the nonoxidative synthesis of ribose and tumor cell proliferation. , 1997, Cancer research.

[108]  T. K. Hunt,et al.  Wound tissue oxygen tension predicts the risk of wound infection in surgical patients. , 1997, Archives of surgery.

[109]  W. Souba,et al.  Regulation of glutamine synthetase in human breast carcinoma cells and experimental tumors. , 1997, Surgery.

[110]  D. Vertommen,et al.  Phosphorylation and Activation of Heart 6-Phosphofructo-2-kinase by Protein Kinase B and Other Protein Kinases of the Insulin Signaling Cascades* , 1997, The Journal of Biological Chemistry.

[111]  R. Sakakibara,et al.  Characterization of a human placental fructose-6-phosphate, 2-kinase/fructose-2,6-bisphosphatase. , 1997, Journal of biochemistry.

[112]  Karl Brand,et al.  Aerobic glycolysis by proliferating cells: a protective strategy against reactive oxygen species 1 , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[113]  E. Newsholme,et al.  Aspects of glutamine metabolism in human tumour cells , 1997, Biochemistry and molecular biology international.

[114]  Rakesh K. Jain,et al.  Interstitial pH and pO2 gradients in solid tumors in vivo: High-resolution measurements reveal a lack of correlation , 1997, Nature Medicine.

[115]  K. Takase,et al.  [T cell activation]. , 1995, Ryumachi. [Rheumatism].

[116]  P. Calder,et al.  Fuel utilization by cells of the immune system , 1995, Proceedings of the Nutrition Society.

[117]  M. Guppy,et al.  Glucose is essential for proliferation and the glycolytic enzyme induction that provokes a transition to glycolytic energy production. , 1994, The Journal of biological chemistry.

[118]  L. Filgueira,et al.  Exogenous glutamine requirement is confined to late events of T cell activation , 1993, Journal of cellular biochemistry.

[119]  R. Curi,et al.  Pyruvate is a lipid precursor for rat lymphocytes in culture: evidence for a lipid exporting capacity. , 1993, Biochemistry and molecular biology international.

[120]  F. Buttgereit,et al.  ConA induced changes in energy metabolism of rat thymocytes , 1992, Bioscience Reports.

[121]  P. Bhathal,et al.  Quantitation of G0 and G1 phase cells in primary carcinomas. Antibody to M1 subunit of ribonucleotide reductase shows G1 phase restriction point block. , 1991, The Journal of clinical investigation.

[122]  E. Newsholme,et al.  Application of metabolic-control logic to fuel utilization and its significance in tumor cells. , 1991, Advances in enzyme regulation.

[123]  B. Nelson,et al.  Expression of a new set of glycolytic isozymes in activated human peripheral lymphocytes. , 1990, Biochimica et biophysica acta.

[124]  J. Mccormack,et al.  Role of calcium ions in regulation of mammalian intramitochondrial metabolism. , 1990, Physiological reviews.

[125]  E. Newsholme,et al.  Maximum activities of key enzymes of glycolysis, glutaminolysis, pentose phosphate pathway and tricarboxylic acid cycle in normal, neoplastic and suppressed cells. , 1990, The Biochemical journal.

[126]  P. Newsholme,et al.  Rates of utilization of glucose, glutamine and oleate and formation of end-products by mouse peritoneal macrophages in culture. , 1989, The Biochemical journal.

[127]  M. Díaz-Guerra,et al.  Phorbol 12,13-dibutyrate and mitogens increase fructose 2,6-bisphosphate in lymphocytes. Comparison of lymphocyte and rat-liver 6-phosphofructo-2-kinase. , 1988, European journal of biochemistry.

[128]  B. Nelson,et al.  Effect of phorbol myristate acetate and concanavalin A on the glycolytic enzymes of human peripheral lymphocytes. , 1988, Biochimica et biophysica acta.

[129]  L. Bassalyk,et al.  Hexokinase isoenzymes in the diagnosis of gastric and esophageal neoplasms. , 1987, Neoplasma.

[130]  Bassalyk Ls,et al.  Hexokinase isoenzymes in the diagnosis of gastric and esophageal neoplasms. , 1987 .

[131]  I. Clark,et al.  Effect of antioxidants on primary alloantigen-induced T cell activation and proliferation. , 1986, Journal of immunology.

[132]  B Crabtree,et al.  The role of high rates of glycolysis and glutamine utilization in rapidly dividing cells , 1985, Bioscience reports.

[133]  B. Silvestrini,et al.  Effect of lonidamine on the aerobic glycolysis of normal and phytohemagglutinin-stimulated human peripheral blood lymphocytes. , 1985, Experimental and molecular pathology.

[134]  M. Ookhtens,et al.  Liver and adipose tissue contributions to newly formed fatty acids in an ascites tumor. , 1984, The American journal of physiology.

[135]  A. Mellors,et al.  Mitogen effects on lipid metabolism during lymphocyte activation. , 1983, Molecular immunology.

[136]  J. Stucki.  The optimal efficiency and the economic degrees of coupling of oxidative phosphorylation. , 1980, European journal of biochemistry.

[137]  D. Roos,et al.  Changes in the carbohydrate metabolism of mitogenically stimulated human peripheral lymphocytes. 3. Stimulation by tuberculin and allogeneic cells. , 1973, Experimental Eye Research.

[138]  D. Roos,et al.  Changes in the carbohydrate metabolism of mitogenically stimulated human peripheral lymphocytes. II. Relative importance of glycolysis and oxidative phosphorylation on phytohaemagglutinin stimulation. , 1973, Experimental cell research.

[139]  H. Morris,et al.  The role of glutamine in the oxidative metabolism of malignant cells. , 1972, Cancer research.

[140]  C. J. Hedeskov.  Early effects of phytohaemagglutinin on glucose metabolism of normal human lymphocytes. , 1968, The Biochemical journal.

[141]  W. Munyon,et al.  The relation between glucose utilization, lactic acid production and utilization and the growth cycle of L strain fibroblasts. , 1959, Experimental cell research.

[142]  H. Hiatt,et al.  A comparison of C14-labeling patterns in deoxyribose and ribose in mammalian cells. , 1958, Archives of biochemistry and biophysics.

[143]  O. Warburg,et al.  [Metabolism of leukocytes]. , 1958, Zeitschrift fur Naturforschung. Teil B, Chemie, Biochemie, Biophysik, Biologie und verwandte Gebiete.

[144]  O. Warburg,et al.  Stoffwechsel der weißen Blutzellen , 1958 .

[145]  O. Warburg.  On respiratory impairment in cancer cells. , 1956, Science.

[146]  O. Warburg.  [Origin of cancer cells]. , 1956, Oncologia.

[147]  S. Weinhouse.  On respiratory impairment in cancer cells. , 1956, Science.

[148]  H. Eagle,et al.  Nutrition needs of mammalian cells in tissue culture. , 1955, Science.